Article ID Journal Published Year Pages File Type
10217943 Gastrointestinal Endoscopy 2018 8 Pages PDF
Abstract
In expert hands, the novel MBM device proved to be effective for resection of early neoplastic lesions in BE, with successful ER in 97% of procedures. Severe adverse events were rare and were effectively managed endoscopically or conservatively. (Clinical trial registration number: NCT02482701.)
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , , , , , , , , , , , , , , , , , , , , , ,